Oritavancin

Results: 14



#Item
1BMJ 2015;350:h1453 doi: [removed]bmj.h1453  Page 1 of 4 Feature

BMJ 2015;350:h1453 doi: [removed]bmj.h1453 Page 1 of 4 Feature

Add to Reading List

Source URL: press.psprings.co.uk

Language: English - Date: 2015-03-20 12:45:30
2Staphylococcaceae / Bacterial diseases / Eli Lilly and Company / Glycopeptide antibiotics / Vancomycin / Staphylococcus aureus / Antibiotic resistance / Oritavancin / Chloramphenicol / Bacteria / Gram-positive bacteria / Microbiology

ARTICLE doi:[removed]nature14098 A new antibiotic kills pathogens without detectable resistance

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2015-02-25 13:15:39
3Variation of registered chemical product Rilexine 75 Palatable Flavoured Cephalexin Antibiotic tablets for cats and dogs - Advice Summary

Variation of registered chemical product Rilexine 75 Palatable Flavoured Cephalexin Antibiotic tablets for cats and dogs - Advice Summary

Add to Reading List

Source URL: archive.apvma.gov.au

Language: English - Date: 2014-06-30 08:20:28
4Rationale for new or revised EUCAST clinical breakpoints Derek Brown ECCMID 2011, Milan  Setting breakpoints in EUCAST

Rationale for new or revised EUCAST clinical breakpoints Derek Brown ECCMID 2011, Milan Setting breakpoints in EUCAST

Add to Reading List

Source URL: www.eucast.org

Language: English - Date: 2011-05-25 13:06:52
5Oritavancin / Medicine / Biology / Targanta Therapeutics Corporation / Pharmacology / Food and Drug Administration / Methicillin-resistant Staphylococcus aureus / New Drug Application / Skin and skin structure infection / Eli Lilly and Company / Glycopeptide antibiotics / Pharmaceutical sciences

Date Manufacturer Product Indication Biologic or Drug Reason/Comments[removed] JNJ Paliperidone Palmitate Schizophrenia Drug N/A[removed] BioDelivery Sciences  Bema Fentanyl, which will be marketed in the US as Onsolis

Add to Reading List

Source URL: www.eyeonfda.com

Language: English - Date: 2010-11-01 16:40:13
6Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for IS

Promoting Innovation in Drug Development: Understanding the Current Regulatory Environment Nicholas S. Downing, MD (with Nilay D. Shah, PhD; Harlan M. Krumholz, MD, SM; and Joseph S. Ross, MD, MHS) Project Summary for IS

Add to Reading List

Source URL: isps.yale.edu

Language: English - Date: 2014-07-17 11:15:56
7Peer-Reviewed Publications 1. Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagacé-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Ceftolozane/Tazobactam: A novel cep

Peer-Reviewed Publications 1. Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagacé-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Ceftolozane/Tazobactam: A novel cep

Add to Reading List

Source URL: umanitoba.ca

Language: English - Date: 2014-09-12 18:21:41
8Opportunities for Interactions with FDA: CDER and CDRH Perspectives

Opportunities for Interactions with FDA: CDER and CDRH Perspectives

Add to Reading List

Source URL: www.fda.gov

Language: English
9BIOTECH’S MOST RESPECTED NEWS SOURCE FOR OVER 15 YEARS  BIOWORLD TODAY

BIOTECH’S MOST RESPECTED NEWS SOURCE FOR OVER 15 YEARS BIOWORLD TODAY

Add to Reading List

Source URL: www.bioworld.com

Language: English - Date: 2012-08-21 06:05:33
10

PDF Document

Add to Reading List

Source URL: media.integratir.com

Language: English - Date: 2007-10-05 18:19:03